Charbel Issa P - Search Results

1

Progression of Vision Loss in Macular Telangiectasia Type 2.

Heeren TF, Clemons T, Scholl HP, Bird AC, Holz FG, Charbel Issa P. Heeren TF, et al. Among authors: charbel issa p. Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3905-12. doi: 10.1167/iovs.15-16915. Invest Ophthalmol Vis Sci. 2015. PMID: 26070062

2

[The complement system and its possible role in the pathogenesis of age-related macular degeneration (AMD)].

Charbel Issa P, Scholl HP, Holz FG, Knolle P, Kurts C. Charbel Issa P, et al. Ophthalmologe. 2005 Nov;102(11):1036-42. doi: 10.1007/s00347-005-1269-4. Ophthalmologe. 2005. PMID: 16215754 Review. German.

3

A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss.

Ebermann I, Scholl HP, Charbel Issa P, Becirovic E, Lamprecht J, Jurklies B, Millán JM, Aller E, Mitter D, Bolz H. Ebermann I, et al. Among authors: charbel issa p. Hum Genet. 2007 Apr;121(2):203-11. doi: 10.1007/s00439-006-0304-0. Epub 2006 Dec 15. Hum Genet. 2007. PMID: 17171570

4

Truncating mutation of the DFNB59 gene causes cochlear hearing impairment and central vestibular dysfunction.

Ebermann I, Walger M, Scholl HP, Charbel Issa P, Lüke C, Nürnberg G, Lang-Roth R, Becker C, Nürnberg P, Bolz HJ. Ebermann I, et al. Among authors: charbel issa p. Hum Mutat. 2007 Jun;28(6):571-7. doi: 10.1002/humu.20478. Hum Mutat. 2007. PMID: 17301963

5

An update on the genetics of age-related macular degeneration.

Scholl HP, Fleckenstein M, Charbel Issa P, Keilhauer C, Holz FG, Weber BH. Scholl HP, et al. Among authors: charbel issa p. Mol Vis. 2007 Feb 7;13:196-205. Mol Vis. 2007. PMID: 17327825 Free PMC article. Review.

6

Microperimetric assessment of patients with type 2 idiopathic macular telangiectasia.

Charbel Issa P, Helb HM, Rohrschneider K, Holz FG, Scholl HP. Charbel Issa P, et al. Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3788-95. doi: 10.1167/iovs.06-1272. Invest Ophthalmol Vis Sci. 2007. PMID: 17652753

7

Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.

Charbel Issa P, Holz FG, Scholl HP. Charbel Issa P, et al. Ophthalmology. 2007 Sep;114(9):1736-42. doi: 10.1016/j.ophtha.2007.03.079. Ophthalmology. 2007. PMID: 17822979

8

[Unilateral pigmented paravenous retinochoroidal atrophy].

Charbel Issa P, Scholl HP, Helb HM, Fleckenstein M, Inhetvin-Hutter C, Holz FG. Charbel Issa P, et al. Klin Monbl Augenheilkd. 2007 Oct;224(10):791-3. doi: 10.1055/s-2007-963600. Klin Monbl Augenheilkd. 2007. PMID: 17952824 German.

9

Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia.

Charbel Issa P, Helb HM, Holz FG, Scholl HP; MacTel Study Group. Charbel Issa P, et al. Am J Ophthalmol. 2008 Jan;145(1):169-175. doi: 10.1016/j.ajo.2007.08.028. Epub 2007 Nov 5. Am J Ophthalmol. 2008. PMID: 17981256

10

A new diagnostic approach in patients with type 2 macular telangiectasia: confocal reflectance imaging.

Charbel Issa P, Finger RP, Helb HM, Holz FG, Scholl HP. Charbel Issa P, et al. Acta Ophthalmol. 2008 Jun;86(4):464-5. doi: 10.1111/j.1600-0420.2007.01041.x. Epub 2007 Nov 17. Acta Ophthalmol. 2008. PMID: 18028239 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters